Cargando…

Effects of ACEI and ARB on COVID-19 patients: A meta-analysis

BACKGROUND: The clinical use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin-receptor blockers (ARB) in patients with COVID-19 infection remains controversial. Therefore, we performed a meta-analysis on the effects of ACEI/ARB on disease symptoms and laboratory tests in hypertensi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Yang, Sun, Shaoqing, Cai, Jianing, Zeng, Linwen, Wang, Shihui, Wang, Suhuai, Li, Jingjie, Sun, Lin, Huo, Jianmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	COVID-19 and the Renin-Angiotensin-Aldosterone System
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747108/ https://www.ncbi.nlm.nih.gov/pubmed/33325306 http://dx.doi.org/10.1177/1470320320981321

Ejemplares similares

Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression
por: Pranata, Raymond, et al.
Publicado: (2020)

COVID-19 and the pulmonary vascular injury
por: Dai, Hai-Long, et al.
Publicado: (2020)

Cardiovascular disease, heart failure and COVID-19
por: Faconti, Luca, et al.
Publicado: (2020)

In vitro analysis of the renin–angiotensin system and inflammatory gene transcripts in human bronchial epithelial cells after infection with severe acute respiratory syndrome coronavirus
por: Turk, Can, et al.
Publicado: (2020)

Could angiotensin-converting enzyme 1 I/D polymorphism be a modificator of COVID-19 response in different populations, diseases, and/or conditions?
por: Dević Pavlić, Sanja, et al.
Publicado: (2020)

Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension
por: Cure, Erkan, et al.
Publicado: (2020)

Angiotensin II, III, and IV may be important in the progression of COVID-19
por: Cure, Erkan, et al.
Publicado: (2020)

Countermeasure and therapeutic: A(1–7) to treat acute respiratory distress syndrome due to COVID-19 infection
por: Soto, Maira, et al.
Publicado: (2020)

COVID-19 and hypertension
por: Kulkarni, Spoorthy, et al.
Publicado: (2020)

The Renin-Angiotensin system and SARS-CoV-2 infection: A role for the ACE2 receptor?
por: Sever, Peter, et al.
Publicado: (2020)

COVID-19: The race for a vaccine
por: Lockey, Emily
Publicado: (2020)

The controversy of using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 patients
por: Harky, Amer, et al.
Publicado: (2021)

Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads
por: Hoevenaar, Martijn, et al.
Publicado: (2020)

Clinical characteristics of COVID-19 with cardiac injury: a systematic review and meta-analysis
por: Zeng, Linwen, et al.
Publicado: (2020)

Application of machine learning to predict the occurrence of arrhythmia after acute myocardial infarction
por: Wang, Suhuai, et al.
Publicado: (2021)

Serum aldosterone effect on left ventricular structure and diastolic function in essential hypertension
por: Al‐Hashedi, Ekhlas Mahmoud, et al.
Publicado: (2022)

WCN23-0291 USE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACEIs) AND ANGIOTENSIN-RECEPTOR BLOCKERS (ARBs) AND INCIDENCE OF PNEUMONIA OR INFLUENZA OR COVID-19: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Qin, X., et al.
Publicado: (2023)

Surgery based on computed tomography images might be feasible for primary aldosteronism patients with visible unilateral adenoma
por: Fang, Chen, et al.
Publicado: (2023)

ACEI/ARB Drug Therapy in COVID-19 Patients: Yes Or No?
por: Gong, Jin, et al.
Publicado: (2021)

Effects of ACEIs Versus ARBs on Proteinuria or Albuminuria in Primary Hypertension: A Meta-Analysis of Randomized Trials
por: Xu, Rui, et al.
Publicado: (2015)

ACEIs and ARBs and Their Correlation with COVID-19: A Review
por: Yehualashet, Awgichew Shewasinad, et al.
Publicado: (2020)

The role of ACEIs/ARBs in COVID-19: Friend or foe?
por: Zhou, Zhe, et al.
Publicado: (2020)

Withdrawal of ACEIs or ARBs in hospitalised patients with COVID-19
Publicado: (2021)

Adrenocorticotropic hormone application lowered aldosterone/cortisol value on dominant side without superior surgical outcomes during adrenal venous sampling
por: Lin, Lede, et al.
Publicado: (2023)

ACEI inhibitors and ARBs do not increase severity of COVID-19
Publicado: (2020)

Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB
por: Rico-Mesa, Juan Simon, et al.
Publicado: (2020)

Is there a difference in the effect between the ACEI and ARB on COVID‐19?
por: Chen, Jie, et al.
Publicado: (2020)

Personalized prescription of ACEI/ARBs for hypertensive COVID-19 patients
por: Bertsimas, Dimitris, et al.
Publicado: (2021)

The clinical efficacy of fluticasone propionate combined with ACEI/ARB in the treatment of immunoglobulin A nephropathy
por: Sun, Liping, et al.
Publicado: (2023)

In-hospital use of ACEI/ARB is associated with lower risk of mortality and critic illness in COVID-19 patients with hypertension
por: Yuan, Yuan, et al.
Publicado: (2020)

ARB might be superior to ACEI for treatment of hypertensive COVID‐19 patients
por: Zhao, Hong‐Jin, et al.
Publicado: (2021)

Cardiovascular and cerebrovascular outcomes in elderly hypertensive patients treated with either ARB or ACEI
por: Ma, Cong, et al.
Publicado: (2012)

MicroRNA Expression Profile in CAD Patients and the Impact of ACEI/ARB
por: Weber, Martina, et al.
Publicado: (2011)

Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?
por: Huang, Ying, et al.
Publicado: (2020)

Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19
por: Khan, Sikandar Hayat, et al.
Publicado: (2020)

Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension
por: Li, Gang, et al.
Publicado: (2020)

Safety of ACEi and ARB in COVID‐19 management: A retrospective analysis
por: Kumar, Sabina, et al.
Publicado: (2022)

ARNI versus ACEI/ARB in Reducing Cardiovascular Outcomes after Myocardial Infarction
por: She, Jianqing, et al.
Publicado: (2021)

Pentoxifylline plus ACEIs/ARBs for proteinuria and kidney function in chronic kidney disease: a meta-analysis
por: Liu, Dong, et al.
Publicado: (2017)

ACEI/ARB use and risk of infection or severity or mortality of COVID-19: A systematic review and meta-analysis
por: Zhang, Xue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1cejrnfsdc8j3atbq4qkdopv6b